Celldex Therapeutics
CLDX
CLDX
48 hedge funds and large institutions have $9.42M invested in Celldex Therapeutics in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
11% less funds holding
Funds holding: 54 → 48 (-6)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
48
Holding in Top 10
1
Calls
$91K
Puts
$39K
Top Buyers
| 1 | +$199K | |
| 2 | +$47.5K | |
| 3 | +$35K | |
| 4 |
Morgan Stanley
New York
|
+$26.6K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$20.8K |
Top Sellers
| 1 | -$350K | |
| 2 | -$156K | |
| 3 | -$36K | |
| 4 |
VF
Virtu Financial
New York
|
-$30K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$23K |